ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 162 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,461,588 | +3.0% | 57,205 | +15.6% | 0.01% | 0.0% |
Q2 2023 | $1,419,488 | +34.0% | 49,494 | +12.0% | 0.01% | +25.0% |
Q1 2023 | $1,059,594 | +73.0% | 44,205 | +22.4% | 0.00% | +300.0% |
Q4 2022 | $612,612 | +45.5% | 36,121 | +27.3% | 0.00% | 0.0% |
Q3 2022 | $421,000 | -15.1% | 28,382 | -9.9% | 0.00% | 0.0% |
Q2 2022 | $496,000 | -33.2% | 31,496 | +57.0% | 0.00% | 0.0% |
Q4 2021 | $742,000 | +183.2% | 20,059 | +158.7% | 0.00% | – |
Q2 2021 | $262,000 | -75.8% | 7,754 | -70.4% | 0.00% | -100.0% |
Q1 2021 | $1,082,000 | +45.4% | 26,206 | +52.8% | 0.00% | +100.0% |
Q4 2020 | $744,000 | -16.5% | 17,149 | -17.4% | 0.00% | -66.7% |
Q3 2020 | $891,000 | +4.2% | 20,762 | +13.5% | 0.00% | -25.0% |
Q2 2020 | $855,000 | +232.7% | 18,298 | -3.4% | 0.00% | +100.0% |
Q1 2020 | $257,000 | -24.4% | 18,945 | -39.4% | 0.00% | 0.0% |
Q4 2019 | $340,000 | +125.2% | 31,284 | +112.2% | 0.00% | +100.0% |
Q3 2019 | $151,000 | +15000.0% | 14,740 | +10136.1% | 0.00% | – |
Q2 2019 | $1,000 | – | 144 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DFPG INVESTMENTS, LLC | 183,803 | $9,359,000 | 5.00% |
DAFNA Capital Management LLC | 229,652 | $9,852,000 | 3.20% |
HealthCor Management, L.P. | 1,594,452 | $68,402,000 | 2.74% |
Capital Impact Advisors, LLC | 110,000 | $4,719,000 | 1.40% |
Cormorant Asset Management, LP | 700,000 | $30,030,000 | 1.16% |
ARK Investment Management | 2,495,842 | $107,072,000 | 0.64% |
Millrace Asset Group, Inc. | 18,087 | $776,000 | 0.63% |
COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,168,000 | 0.54% |
Endurant Capital Management LP | 34,485 | $1,479,000 | 0.44% |
HealthCor Management, L.P. | 200,000 | $8,580,000 | 0.34% |